Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by Odelayon Aug 16, 2018 12:26pm

108 Views

Post# 28472610

Safe to buy

I guess nothing that happens on the Venture should surprise me, but it seems incredible how successfully this has been shorted to these levels.

I have no fear in buying more at any price under 10 cents. Bought another 25k yesterday, even though the chart did indicate the bottom may still be lower. Not worth the risk of missing the under 10 cent sale.

Hopefully, all the fear tactics will dry up soon, or the people reading press releases will start actually paying attention to what they say.

GLTA!

Bullboard Posts

How a truck transportation and logistics company leverages acquisitions and technology